Latest Cancer News

FDA Approves Aliqopa for Relapsed Follicular Lymphoma (05-23-2018)
The U.S. Food and Drug Administration (FDA) granted accelerated approval to Aliqopa® (copanlisib), a novel precision cancer medicine that inhibits phosphatidylinositol 3-kinase (PI3K), for the treatment... Continue Reading

FDA Approves Kymriah for Treatment of Relapsed or Refractory Large B-Cell Lymphoma (05-21-2018)
On May 1, 2018, the United States Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel), a CD19-directed genetically modified autologous T-cell immunotherapy, for treatment of adult patients... Continue Reading

FDA Approves Aimovig, A Novel Preventive Treatment for Migraine Headaches (05-21-2018)
According to Dr. Jessica Ailani, MD, associate professor of neurology at MedStar’s Georgetown University Hospital and director of the MedStar Georgetown Headache Center, migraines affect over 36 million... Continue Reading

More Cancer News

Locations

Jackson
322 Hospital Boulevard
Jackson, TN 38305
731-668-1668
800-870-5471
Dyersburg
440 Wilkinson Drive
Dyersburg, TN 38024
731 285-2211
888-748-8511
Paris
1290 Kelley Drive
Paris, TN 38242
731-644-3522
800-221-0948
Union City
1209 Reelfoot Ave.
Union City, TN 38261
731-884-8611
888-941-8611